3,4-dihydroxyphenylacetic acid has been researched along with trifluoperazine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clow, A; Jenner, P; Marsden, CD; Theodorou, A | 4 |
Bruno, F; Bugatti, A; Cattabeni, F; Groppetti, A; Maggi, A; Parenti, M; Racagni, G | 1 |
Crowley, TJ; Hoehn, MM; Rutledge, CO | 1 |
Andersen, H; Braestrup, C; Randrup, A | 1 |
McMillen, BA | 1 |
Brown, AM; Burke, WJ; Conway, AD; Jain, JC; Kristal, BS; Li, SW; Ulluci, PA | 1 |
9 other study(ies) available for 3,4-dihydroxyphenylacetic acid and trifluoperazine
Article | Year |
---|---|
Neuroleptic drugs and the dopamine hypothesis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Limbic System; Rats; Receptors, Dopamine; Schizophrenia; Thioridazine; Trifluoperazine | 1979 |
Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Apomorphine; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Male; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Time Factors; Trifluoperazine | 1979 |
Evidences for a direct action in striatum of dopaminergic receptor antagonists mediating DOPAC formation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Haloperidol; Male; Oxotremorine; Phenylacetates; Rats; Receptors, Dopamine; Trifluoperazine | 1978 |
The Parkinsonian syndrome and its dopamine correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dopamine; Extrapyramidal Tracts; Female; Homovanillic Acid; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Schizophrenia; Syndrome; Trifluoperazine | 1977 |
Apomorphine-induced stereotyped biting in the tortoise in relation to dopaminergic mechanisms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior; Behavior, Animal; Brain; Dopamine; Haloperidol; Homovanillic Acid; Humans; Receptors, Drug; Stereotyped Behavior; Trifluoperazine; Turtles | 1975 |
Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Body Weight; Buspirone; Dopamine; Female; Haloperidol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Synaptic Transmission; Time Factors; Trifluoperazine; Tyrosine 3-Monooxygenase | 1985 |
Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding Sites; Corpus Striatum; Cyclic AMP; Dopamine; Homovanillic Acid; Male; Rats; Receptors, Dopamine; Spiperone; Thioridazine; Time Factors; Trifluoperazine | 1980 |
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Body Weight; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Male; Motor Activity; Mouth; Movement; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substance Withdrawal Syndrome; Thioridazine; Time Factors; Trifluoperazine | 1980 |
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Aminobenzoic Acid; Aminobenzoates; Animals; Aristolochic Acids; Cell Death; Cell Differentiation; Cyclosporine; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; Ion Channels; Male; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nerve Growth Factor; para-Aminobenzoates; Parkinson Disease; PC12 Cells; Phenanthrenes; Rats; Rats, Inbred F344; Respiration; Rotenone; Trifluoperazine; Uncoupling Agents | 2001 |